Bloomberg reported on 31 July that President Donald Trump has issued an ultimatum to 17 of the world's leading pharmaceutical firms demanding that they slash prices for American consumers to match what is paid in other developed nations, setting a 60-day deadline for voluntary compliance. The move targets industry titans including Pfizer Inc, Eli Lilly & Co, and Novo Nordisk A/S.